Skip to main content
. 2023 Aug 9;10(8):ENEURO.0106-23.2023. doi: 10.1523/ENEURO.0106-23.2023

Table 2.

Summary of findings

Method Measure CORT Reelin Ketamine
Behavior FST immobility
FST swimming
FST climbing
FST latency to immobility
SPT habituation
SPT test
Electrophysiology I/O curve
PTP
LTP
Immunohistochemistry Reelin
Western blotting p-mTOR ↔ (WH and SNP) ↔ (WH and SNP) ↑ (WH) ↔ (SNP)
mTOR ↔ (WH and SNP) ↔ (WH and SNP) ↔ (WH and SNP)
p-GluA1 ↔ (WH and SNP) ↔ (WH and SNP) ↔ (WH and SNP)
GluA1 ↔ (WH and SNP) ↔ (WH and SNP) ↔ (WH and SNP)
p-CREB ↔ (WH and SNP) ↔ (WH and SNP) ↔ (WH and SNP)
CREB ↔ (WH and SNP) ↔ (WH and SNP) ↔ (WH and SNP)
Synapsin I ↔ (WH and SNP) ↔ (WH and SNP) ↔ (WH and SNP)
PSD-95 ↔ (WH and SNP) ↔ (WH and SNP) ↔ (WH and SNP)
GluN2b ↔ (WH and SNP) ↔ (WH and SNP) ↔ (WH and SNP)
p-Erk1/2 ↔ (WH and SNP) ↔ (WH and SNP) ↔ (WH and SNP)

CORT, corticosterone; CREB, cAMP response element-binding protein; Erk1/2, extracellular signal-regulated kinase; FST, forced swim test; I/O, input/output; LTP, long-term potentiation; mTOR, mechanistic target of rapamycin; p-, phosphorylated-; PSD-95, postsynaptic density-95; PTP, post-tetanic potentiation; SPT, sucrose preference test; SNP, synaptoneurosome; WH, whole homogenate. ↑, increased; ↓, decreased; ↔, unchanged.